Myeloblasts expanded from CD34+ bone marrow progenitors of CML patients were shown to secreteten times more HGF, VEGF, FGF-2 and IL-8 compared to healthy donors [97]. This evidence concerns the gene FGF2 and chronic myelogenous leukemia, BCR-ABL1 positive.